Boston Children's Hospital
Boston, Massachusetts, 02215, United States
Location status: Recruiting
Location contact
Darius Ebrahimi-Fakhari, MD, PhD.
CONTACT
Kathryn Yang, MD
CONTACT
NCT Number: NCT06585618
There is limited data on outcomes for children who have undergone deep brain stimulation (DBS) for movement disorders, and individual centers performing this surgery often lack sufficient cases to power research studies adequately. This study aims to develop a multicenter pediatric DBS registry that allows multiple sites to share clinical pediatric DBS data. The primary goals are to enable large-scale, well-powered analyses of the safety and efficacy of DBS in the pediatric population and to further explore and refine DBS as a therapeutic option for children with dystonia and other hyperkinetic movement disorders. Given the current scarcity of evidence available to clinicians, this centralized multicenter repository of clinical data is critical for addressing key research questions and improving clinical practice for pediatric DBS.
Interested in participating?
Request Info0 year–18 year
All sexes
Observational
Boston, Massachusetts, 02215, United States
Location status: Recruiting
Darius Ebrahimi-Fakhari, MD, PhD.
CONTACT
Kathryn Yang, MD
CONTACT
The use of deep brain stimulation (DBS) has expanded to include multiple conditions in children including dystonia, epilepsy, Tourette syndrome and mood disorders. Despite its growing application, DBS remains a low-volume procedure in most pediatric centers, which limits opportunities for large-scale research studies. To overcome this challenge, an international data-sharing platform is essential for advancing knowledge about DBS in pediatric patients, particularly concerning surgical techniques and patient outcomes across various conditions.
This study aims to establish a multicenter pediatric DBS registry. With limited data on pediatric DBS outcomes and a small number of cases at individual centers, there is a need for a comprehensive registry to enable large-scale, well-powered analyses of DBS safety and effectiveness. The primary goals of this study are to:
Secondary objectives include:
The study will involve both prospective and retrospective data collection from pediatric DBS patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Time frame: 5 years
This study will define DBS as a therapeutic option for children with dystonia, other hyperkinetic movement disorders, or epilepsy.
Time frame: 5 years
Secondary objectives will focus on using the data collected to answer important research questions such as :
Contact information is provided by the study sponsor or research team.
Darius Ebrahimi-Fakhari, MD, PhD
CONTACT
Kathryn Yang, MBChB, FRCPC
CONTACT
Boston Children's Hospital
Other
Multicenter Pediatric Deep Brain Stimulation Registry
Acronym: DBS-R
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01019343
Basal Ganglia Diseases, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT06912841
ADCY5, Central Nervous System Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT02252380
Ataxia, Basal Ganglia Diseases
Toronto, Ontario, Canada
View Trial DetailsNCT06553625
Basal Ganglia Diseases, Brain Diseases
Cologne, Germany
View Trial Details